Publications for All Faculty
Inertial focusing cytometer with integrated optics for particle characterization.
BCG-induced trained immunity in NK cells: Role for non-specific protection to infection.
Genetics of immune-mediated disorders: from genome-wide association to molecular mechanism.
Pathogens.
Next-Gen Sequencing-Based Mapping and Identification of Ethyl Methanesulfonate-Induced Mutations in Arabidopsis thaliana.
Chain-Length Heterogeneity Allows for the Assembly of Fatty Acid Vesicles in Dilute Solutions.
Twists and turns: my career path and concerns about the future.
Pathogens.
Genome editing: a tool for research and therapy: towards a functional understanding of variants for molecular diagnostics using genome editing.
An Image-Based Genetic Assay Identifies Genes in T1D Susceptibility Loci Controlling Cellular Antiviral Immunity in Mouse.
CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling.
Transmembrane adaptor protein PAG/CBP is involved in both positive and negative regulation of mast cell signaling.
Small-molecule control of cytokine function: new opportunities for treating immune disorders.
Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia.
Crystal Structure Studies of RNA Duplexes Containing s2U:A and s2U:U Base Pairs.
Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation.
Treatment of heterotopic ossification through remote ATP hydrolysis.
Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity.
mTOR- and HIF-1?-mediated aerobic glycolysis as metabolic basis for trained immunity.
Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damage.
HIV-1 Protein Nef Inhibits Activity of ATP Binding Cassette Transporter A1 by Targeting Endoplasmic Reticulum Chaperone Calnexin.
Multivariate inference of pathway activity in host immunity and response to therapeutics.
An alteration in ATG16L1 stability in Crohn disease.
Small-molecule screening identifies inhibition of salt-inducible kinases as a therapeutic strategy to enhance immunoregulatory functions of dendritic cells.
I?B kinase ? (IKBKB) mutations in lymphomas that constitutively activate canonical nuclear factor ?B (NF?B) signaling.